Summary & Overview
HCPCS G0144: Cervical or Vaginal Cytopathology Screening, Automated
HCPCS Level II code G0144 covers automated screening cytopathology for cervical or vaginal specimens collected in preservative fluid and processed via thin-layer preparation under physician supervision. This code defines a laboratory screening service that supports early detection of cervical and vaginal epithelial abnormalities and contributes to national preventive care and cancer screening efforts. Its use affects laboratory workflows, claims processing, and quality measurement for cytology screening programs.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical service represented by G0144, typical sites of service, common billing modifiers, and the role of automated thin-layer and automated screening technologies in cytopathology workflows. The publication summarizes national reimbursement and billing considerations, highlights relevant payer coverage patterns, and outlines operational implications for laboratories and pathology groups. The content provides benchmarks and policy-context information relevant to billing teams, laboratory managers, and revenue cycle professionals. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code G0144 represents screening cytopathology of cervical or vaginal samples collected in preservative fluid and prepared using an automated thin-layer method, with screening performed by an automated system under physician supervision. The service is a laboratory-based cytology screening procedure intended to detect cellular abnormalities of the cervix or vagina.
Service type: Laboratory cytopathology screening using automated thin-layer preparation and automated screening systems, performed under physician supervision.
Typical site of service: Clinical laboratory or pathology laboratory (laboratory-based service).
Clinical & Coding Specifications
Clinical Context
A patient-presenting scenario: A 34-year-old woman attends a primary care or gynecology clinic for a routine cervical cancer screening. She has no acute symptoms, presents for an annual well-woman exam, and requests screening following guidelines. A clinician (family medicine physician, nurse practitioner, or gynecologist) collects a cervical or vaginal specimen using a brush or spatula and transfers cellular material into a preservative fluid vial (liquid-based cytology). The specimen is prepared with an automated thin-layer method (e.g., ThinPrep or SurePath) and processed through an automated screening system with physician supervision. The laboratory performs primary automated screening of the cytology slides/virtual images; a pathologist or cytotechnologist reviews flagged slides and finalizes interpretation under supervising physician oversight. Typical site of service is an outpatient clinic or ambulatory surgery center with specimens sent to a clinical laboratory or hospital pathology department. Common clinical workflow steps: sample collection at the clinic visit, specimen accessioning and automated thin-layer preparation in the lab, automated screening by computer-assisted system, review and sign-out by a laboratorian under physician supervision, and reporting of results to the ordering clinician. Typical indications include routine cervical cancer screening, follow-up of prior abnormal cytology, or surveillance after treatment of cervical dysplasia.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component |